However, Zhao and coworkers reported that systemic infusion of CAR T cells that were constructed based on the N-terminus of mesothelin did not eliminate tumor cells in mice while, in contrast, our MSLN-CAR T cells were effective at shrinking ovarian cancer cell tumors in NCG mice. This evidence concerns the gene MSLN and ovarian carcinoma.